HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 89 filers reported holding HARPOON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $630,000 | -65.9% | 329,842 | -11.4% | 0.01% | -58.3% |
Q1 2022 | $1,849,000 | -25.1% | 372,097 | +13.9% | 0.01% | -29.4% |
Q4 2021 | $2,467,000 | +258.6% | 326,808 | +275.2% | 0.02% | +240.0% |
Q3 2021 | $688,000 | -35.6% | 87,103 | +35.3% | 0.01% | -44.4% |
Q4 2020 | $1,069,000 | -7.8% | 64,388 | -5.6% | 0.01% | -25.0% |
Q3 2020 | $1,159,000 | +23.8% | 68,225 | +21.0% | 0.01% | +20.0% |
Q2 2020 | $936,000 | +175.3% | 56,371 | +92.0% | 0.01% | +150.0% |
Q1 2020 | $340,000 | – | 29,353 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,524,425 | $58,818,000 | 23.77% |
New Leaf Venture Partners, L.L.C. | 2,921,405 | $37,978,000 | 10.18% |
EcoR1 Capital, LLC | 1,348,423 | $17,529,000 | 1.77% |
SPHERA FUNDS MANAGEMENT LTD. | 374,031 | $4,862,000 | 0.66% |
Orbimed Advisors | 2,446,409 | $31,803,000 | 0.49% |
Cormorant Asset Management, LP | 649,994 | $8,450,000 | 0.48% |
Fosun International Ltd | 323,400 | $4,205,000 | 0.28% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 285,000 | $3,705,000 | 0.13% |
Baker Brothers Advisors | 214,285 | $2,786,000 | 0.02% |
UBS Group AG | 1,062 | $14,000 | 0.00% |